Chronic lymphocytic leukemia (CLL), the most common leukemia in adults in western countries, is characterized by the progressive accumulation of mature-appearing clonal B cells expressing CD5, CD23, and CD19 surface markers in the blood, bone marrow and secondary lymphatic tissues. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.